Dexamethasone, Which Researchers Call A Big Breakthrough In COVID-19 Treatment

JAKARTA - The Japanese Ministry of Health approved dexamethasone as part of the treatment for COVID-19. Tests in the UK have shown the drug can reduce the death rate in hospitalized COVID-19 patients.

The cheap steroid that is very widely used will be used as a treatment option along with remdesivir. Reported by the New York Times, this has even been listed in the handbook of Japanese health workers as a revision of the previous edition.

The Japanese government is optimistic. This revision has been widely announced to local media, Wednesday, July 22. Reportedly, in a trial last month, British researchers found a positive reaction to dexamethasone in helping cure COVID-19 patients.

In fact, dexamethasone is said to be the first drug to save the lives of COVID-19 patients. The findings that the researchers call a major breakthrough in the new coronavirus resistance.

The Japanese authorities, on the same occasion, also announced which companies would produce drugs. Japan's Nichi-Iko Pharmaceutical Co is one they name.